Species belonging to the Bacteroides fragilis group are the most
The cefoxitin resistance rate increased from zero in 1987 to prevalent pathogens among anaerobic bacteria and have the highest 22% in 1995. Two strains displayed decreased susceptibility to resistance rates to antimicrobial agents. Furthermore, some species, ampicillin/sulbactam. Changing rates of resistance to clindasuch as Bacteroides distasonis, Bacteroides thetaiotaomicron, and mycin were observed at different periods. Bacteroides vulgatus, appear to be more resistant than the other Differential susceptibility to clindamycin and cefoxitin of group species [1] . species belonging to the B. fragilis group is shown in figure Although susceptibility testing for anaerobic bacteria is not rou-1. Clindamycin resistance was more frequently detected in tinely performed by some laboratories, the increasing resistance B. distasonis, B. thetaiotaomicron, and B. vulgatus isolates of B. fragilis group isolates emphasizes the need to survey the (9%, 6%, and 5%, respectively). Similar results were observed susceptibility patterns of these organisms [2] . . The changing resistance trends observed here emphasize heart infusion agar (Difco Laboratories, Detroit) was used inthe need of routinely surveying the in vitro susceptibility of stead of Wilkins-Chalgren (WC) medium. WC agar was not anaerobic bacteria. available as the reference medium at the beginning of this study, and we did not find significant differences between the two media for B. fragilis group isolates in previous studies (data not shown).
The following drugs were supplied as standard antimicrobial powders: ampicillin/sulbactam (Pfizer, Buenos Aires), cefoxitin and imipenem (Merck Sharpe & Dohme, Buenos Aires), chloramphenicol (Argentia, Buenos Aires), metronidazole (Rhodia, Buenos Aires), ornidazole (Roche Laboratories, Buenos Aires), meropenem (Zeneca Farma, Buenos Aires), and clindamycin (Upjohn, Buenos Aires). Breakpoints were adopted from NCCLS documents [4] . B. fragilis ATCC 25285 was used as the control. 
